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■ CASE REPORT ■
Introduction
In Japan, the rate of gastric cancer during pregnancy is
reported to be only 0.016% [1]. We report a case of
gastric cancer in pregnancy in which good prognoses
for the mother and the neonate were achieved after
early detection, delivery and treatment.
Case Report
A 32-year-old woman, gravida 6, para 4, presented in
December 2003 in the 18th week of gestation. She was
158 cm tall and had a body mass index of 22.3 prior to
pregnancy. Although there was no family history of
gastric cancer, she smoked 10 cigarettes a day.
The woman had presented at the hospital complain-
ing of epigastric pain, and was diagnosed with acute
gastritis. Her symptoms abated with administration of
an oral H2-blocker. From the 26th week of gestation, she
began vomiting a brown-colored substance, with contin-
uing gastric distress, and was admitted to hospital on
day 0 of the 29th week of gestation for a comprehensive
examination.
On admission, the woman looked pale and com-
plained of an oppressive pain in the right upper quad-
rant. Her stool tested positive for occult blood, with a
hemoglobin level of 10.0 g/dL, but no coagulation dys-
function was detected. Details of observations on admis-
sion are shown in Table 1. Tumor markers were as
follows: carcinoembryonic antigen (CEA), 1.7 ng/mL;
carbohydrate antigen (CA) 19-9, 8 U/mL; squamous
cell carcinoma related antigen (SCC), 1.3 ng/mL; and
neuron-specific enolase, 1.3 mg/mL.
Gastrointestinal endoscopy was performed on day
4 of the 29th week of pregnancy. An ulcer was detected in
the lesser curvature of the stomach (Figure). Hemostasis
by clipping and a biopsy were completed. The results
revealed a moderately to poorly differentiated tubular
adenocarcinoma with signet ring cells. The woman
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tested positive for Helicobacter pylori. Neither ultra-
sonography nor magnetic resonance imaging detected
any metastases.
An elective cesarean section, pylorus gastrectomy,
gallbladder removal, and lymph node dissection were
performed on day 6 of the 30th week of pregnancy. A
Borrmann type III lesion arising from a 3.2 cm × 3.0 cm
ulcer in the lesser curvature of the stomach was ex-
tracted. Pathologic examination showed a poorly dif-
ferentiated adenocarcinoma, a non-solid carcinoma with
signet-ring cells, and no regional lymph node metastasis.
The woman was discharged from hospital on day 18
postoperatively without adjuvant chemotherapy being
performed, and the case was followed up without recur-
rence for 3 years.
The baby was female, weighing 1,274 g upon delivery
and had 1- and 5-minute Apgar scores of 8 and 10,
respectively. The mother had been administered 16 mg
of betamethasone for two consecutive days from day 
0 of the 30th week of pregnancy, and 120 mg of surfac-
tant was administered via tracheal intubation to the
baby as she was suffering from Bomsel grade 1 respira-
tory distress syndrome. On the first day after birth, the
baby suffered an apnea attack after extubation, and
aminophylline was administered until the 33rd day after
birth. She also showed symptoms of hyperbilirubinemia
from the first day after birth and underwent photo-
therapy for 5 days. From the 38th day after birth, the
baby received 0.66 mL/kg per day of ferric pyrophos-
phate syrup to treat the anemia. However, she showed
no signs of retinopathy of prematurity or neurologic
complications, and left hospital on the 75th day after
birth, weighing 2,984 g. She subsequently continued
to develop normally.
Discussion
Gastric cancer in pregnant women is rare, with a fre-
quency of 0.016% amongst Japanese women [1]. Sev-
eral important reports in recent years (Table 2) have
shown that the probability of the mother surviving re-
mains low [1,4–7]. There is often a delay in diagnosing
gastric cancer in pregnant women even when they are
symptomatic, because the symptoms are often taken
to be symptoms of hyperemesis or expansion of the
uterus.
During pregnancy, the mother’s immunity drops as
a result of hormonal changes. According to a report by
Lanciers et al [8], the H. pylori infection rate is signifi-
cantly higher for pregnant women (26.6%) than non-
pregnant women (11.0%) [8]. Furthermore, pregnancy
decreases the secretion of acid in the stomach and
increases mucus production. Added to this, because the
histaminase produced by the placenta deactivates hista-
mine function, the patient exhibits no deterioration of
symptoms caused by the cancerous ulcer [9]. Given that
circulatory blood flow also increases during pregnancy,
Table 1. Data on admission
Height (cm) 164
Weight (kg) 68
Heart rate (/min) 88
Blood pressure (mmHg) 136/77
White blood cell count (/mL) 19,700
Red blood cell count (/mL) 337 × 104
Hemoglobin (g/dL) 10.0
MCV (fL) 89.0
MCH (pg) 29.7
MCHC (%) 33.4
Hematocrit (%) 29.9
Platelet count (/mL) 39.7 × 104
Total bilirubin (mg/dL) 0.9
AST (IU/L) 21
ALT (IU/L) 6
Total protein (g/dL) 7
Amylase (IU/L) 96
Blood urea nitrogen (mg/dL) 13
Creatinine (mg/dL) 0.36
Sodium (mEq/L) 134
Potassium (mEq/L) 3.7
Chloride (mEq/L) 97
Calcium (mEq/L) 8.1
C-reactive protein (mg/dL) 0.6
PT (s) 11.3/10.4 (control)
APTT (s) 24.0/30.3 (control)
MCV = mean corpuscular volume; MCH = mean corpuscular hemoglobin;
MCHC = mean corpuscular hemoglobin concentration; AST = aspartate
aminotransferase; ALT = alanine aminotransferase; PT = prothrombin time;
APTT = activated partial thromboplastin time.
Figure. Gastrointestinal endoscopy showing gastric cancer.
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pregnant women are particularly susceptible to the
rapid growth and spread of cancer.
In the 1930s, Smith [10] reported that the progno-
sis for pregnant women with gastric cancer tended to
be good, as malignant tumor growth was curbed by
pregnancy. However, because many young gastric can-
cer patients suffer from Borrmann type III or IV, their
prognosis is widely regarded as poor, because they often
have histologic cancer, undifferentiated glandular can-
cer, and/or signet-ring cell cancer [2]. Ueo et al [3]
reported that the 3-year survival rate for pregnant
women with gastric cancer was 21.1%. In the present
case, the cancer was Borrmann type III and the fetal
development was normal; we, therefore, prioritized the
mother’s survival and elected for a cesarean section.
However, for cases in which the gastric cancer is at an
early stage, it would usually be preferable to perform
endoscopic surgery and continue the pregnancy for as
long as possible.
Given that the nausea and vomiting arising from
hyperemesis generally improves by the 16th week of
gestation in 90% of cases and by the 20th week of ges-
tation in 99% of cases [5], the presence of protracted
digestive symptoms necessitates prompt assessment of
digestive disorders in the second trimester. Prompt sur-
gical and obstetric intervention should also be per-
formed depending on the stage of pregnancy and the
degree to which the cancer has advanced. Peptidase
secretion changes during pregnancy; and because
there is a lack of subjective symptoms pointing to gas-
tric cancer, early stool and endogastric tests should be
performed in such cases. In the evaluation of treatment
and for the early detection of any recurrence, tumor
markers are usually the means of determining whether
a tumor is benign or malignant.
However, the impact of pregnancy on all the above
factors must be taken into account, and indeed, no
tumor marker elevation was observed in the present
case. Pregnancy has almost no impact on CEA, CA 19-9
or sialyl Tn antigen levels; SCC and sialyl stage-specific
embryonic antigen-1 are impacted slightly by preg-
nancy, but with a positive ratio of 10 to 20, there are
almost no instances in which abnormally high levels
occur.
Metastasis of a malignant tumor to the placenta or
to the baby is extremely rare, and the literature contains
only 67 such cases. Most common among these are
malignant melanomas, which account for 23 of the 67
cases, and only two cases of metastasis of gastric cancer
have been reported [6]. We have followed up this par-
ticular case of gastric cancer in pregnancy, both the
mother and the neonate, for 3 years and have observed
no recurrence or metastasis.
Ta
bl
e 
2.
G
as
tr
ic
 c
an
ce
r i
n 
pr
eg
na
nc
y 
(l
it
er
at
ur
e 
re
vi
ew
)
C
as
e
A
ut
ho
r
A
ge
 (
yr
)
D
ia
gn
os
is
Pa
th
ol
og
y
Tr
ea
tm
en
t
M
et
as
ta
si
s
M
at
er
na
l o
ut
co
m
e
1
Ja
sp
er
s 
et
 a
l [
4]
28
Po
st
 d
el
iv
er
y
Po
or
ly
 d
iff
er
en
tia
te
d 
Po
st
pa
rt
um
 g
as
tr
ec
to
m
y
–
D
ea
th
ad
en
oc
ar
ci
no
m
a
33
Po
st
 d
el
iv
er
y
Po
or
ly
 d
iff
er
en
tia
te
d 
Po
st
pa
rt
um
 g
as
tr
ec
to
m
y,
 
–
Su
rv
iv
al
ad
en
oc
ar
ci
no
m
a
im
m
un
ot
he
ra
py
2
Sh
im
ab
uk
ur
o 
et
 a
l [
7]
35
22
 G
A
Si
gn
et
 ri
ng
 c
el
l c
ar
ci
no
m
a
To
ta
l p
ar
en
te
ra
l n
ut
rit
io
n
B
ra
in
D
ea
th
3
N
ak
ag
aw
a 
[1
]
33
7 
G
A
–
C
he
m
ot
he
ra
py
Pa
nc
re
as
D
ea
th
36
25
 G
A
–
C
he
m
ot
he
ra
py
Pa
nc
re
as
D
ea
th
31
37
 G
A
–
C
he
m
ot
he
ra
py
–
D
ea
th
32
34
 G
A
–
C
he
m
ot
he
ra
py
Pa
nc
re
as
D
ea
th
4
O
zd
em
ir 
et
 a
l [
5]
27
28
 G
A
Si
gn
et
 ri
ng
 c
el
l c
ar
ci
no
m
a
Po
st
pa
rt
um
 g
as
tr
ec
to
m
y,
 
–
Su
rv
iv
al
ch
em
ot
he
ra
py
5
K
ha
tib
 e
t a
l [
6]
26
26
 G
A
Po
or
ly
 d
iff
er
en
tia
te
d 
To
ta
l p
ar
en
te
ra
l n
ut
rit
io
n
Li
ve
r
D
ea
th
ad
en
oc
ar
ci
no
m
a
G
A
 =
ge
st
at
io
na
l a
ge
.
Taiwan J Obstet Gynecol • September 2009 • Vol 48 • No 3 285
Prolonged Hyperemesis in Pregnancy
Thus, the possibility of gastric cancer should not be
disregarded in the treatment of digestive symptoms in
pregnancy. Considering the rapid growth of gastric
cancer in pregnancy, early detection and intervention
are imperative.
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